Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ACXP is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
19 filers reported a long position in ACXP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $48.2K | 31.1K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $40.9K | 26.4K | +6.4% |
| VANGUARD FIDUCIARY TRUST CO | $25.1K | 16.2K | Unchanged |
| JANE STREET GROUP, LLC | $24.4K | 15.7K | -71.2% |
| Prospect Financial Services LLC | $21.4K | 13.8K | Unchanged |
| MORGAN STANLEY | $11.6K | 7.5K | +15.4% |
| Integrated Wealth Concepts LLC | $7.3K | 4.7K | New |
| Tower Research Capital LLC (TRC) | $4.3K | 2.7K | +166.1% |
| WELLS FARGO & COMPANY/MN | $3.6K | 2.3K | Unchanged |
| Westside Investment Management, Inc. | $2.6K | 1.7K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.